company background image
MDXH logo

MDxHealth ENXTBR:MDXH Stock Report

Last Price

€3.02

Market Cap

€82.4m

7D

-5.6%

1Y

-52.3%

Updated

18 Dec, 2023

Data

Company Financials +

MDxHealth SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MDxHealth
Historical stock prices
Current Share Price€3.02
52 Week High€6.90
52 Week Low€1.98
Beta0.79
1 Month Change5.19%
3 Month Change11.44%
1 Year Change-52.29%
3 Year Change-66.07%
5 Year Change-81.31%
Change since IPO-96.03%

Recent News & Updates

Recent updates

Why Investors Shouldn't Be Surprised By MDxHealth SA's (EBR:MDXH) 29% Share Price Plunge

Oct 05
Why Investors Shouldn't Be Surprised By MDxHealth SA's (EBR:MDXH) 29% Share Price Plunge

MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?

Aug 29
MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?

MDxHealth (EBR:MDXH) Is Carrying A Fair Bit Of Debt

Apr 21
MDxHealth (EBR:MDXH) Is Carrying A Fair Bit Of Debt

Is MDxHealth (EBR:MDXH) Using Debt In A Risky Way?

May 05
Is MDxHealth (EBR:MDXH) Using Debt In A Risky Way?

Here's Why MDxHealth (EBR:MDXH) Can Manage Its Debt Despite Losing Money

Nov 08
Here's Why MDxHealth (EBR:MDXH) Can Manage Its Debt Despite Losing Money

MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?

Mar 23
MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?

MDxHealth's (EBR:MDXH) Stock Price Has Reduced 75% In The Past Five Years

Jan 29
MDxHealth's (EBR:MDXH) Stock Price Has Reduced 75% In The Past Five Years

Is MDxHealth (EBR:MDXH) Weighed On By Its Debt Load?

Nov 27
Is MDxHealth (EBR:MDXH) Weighed On By Its Debt Load?

Shareholder Returns

MDXHBE BiotechsBE Market
7D-5.6%-2.4%-1.9%
1Y-52.3%-11.0%0.6%

Return vs Industry: MDXH underperformed the Belgian Biotechs industry which returned -7.7% over the past year.

Return vs Market: MDXH underperformed the Belgian Market which returned 1.2% over the past year.

Price Volatility

Is MDXH's price volatile compared to industry and market?
MDXH volatility
MDXH Average Weekly Movement10.9%
Biotechs Industry Average Movement6.9%
Market Average Movement3.7%
10% most volatile stocks in BE Market7.1%
10% least volatile stocks in BE Market2.6%

Stable Share Price: MDXH's share price has been volatile over the past 3 months.

Volatility Over Time: MDXH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Belgian stocks.

About the Company

FoundedEmployeesCEOWebsite
2003255Mike McGarritymdxhealth.com

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010.

MDxHealth SA Fundamentals Summary

How do MDxHealth's earnings and revenue compare to its market cap?
MDXH fundamental statistics
Market cap€82.41m
Earnings (TTM)-€41.04m
Revenue (TTM)€58.31m

1.4x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDXH income statement (TTM)
RevenueUS$63.69m
Cost of RevenueUS$25.20m
Gross ProfitUS$38.48m
Other ExpensesUS$83.30m
Earnings-US$44.82m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.64
Gross Margin60.42%
Net Profit Margin-70.37%
Debt/Equity Ratio201.8%

How did MDXH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.